drugset / Trial / NCT03756922
A DDI Study of FDL169 and FDL176 in Healthy Subjects
RandomizedSequentialTriple-blindTreatment
Summary
A DDI study to assess the safety, tolerability and pharmacokinetics of both; doses of FDL176 with and without co-administration of FDL169 and doses of FDL169 with and without co-administration of FDL176.
Timeline
- Start
- 2018-11-27
- Primary completion
- 2020-02
- Completion
- 2020-02
Outcome
Outcome not reported
Stopped (Business): “Business reasons”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | FDL169 | Small molecule | — | — |
| Subject | XO-176 | Small molecule | — | — |